Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q1JZ
|
|||
| Former ID |
DIB016797
|
|||
| Drug Name |
Anti-OX40 monoclonal antibody
|
|||
| Synonyms |
Anti-OX40 antibody, Providence Health and Services; Anti-OX40 monoclonal antibody (iv, cancer); Anti-OX40 (iv, cancer), Providence Health and Services; Anti-OX40 monoclonal antibody (iv, cancer), Providence Health and Services
Click to Show/Hide
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Phase 1/2 | [1] | |
| Company |
Providence Health System - Oregon
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01862900) Stereotactic Body Radiation and Monoclonal Antibody to OX40 in Breast Cancer Patients With Metastatic Lesions. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.